These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29868745)

  • 1. Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine.
    Good CB; Hernandez I
    JAMA Intern Med; 2018 Jun; 178(6):873. PubMed ID: 29868745
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential cost-effectiveness of adjuvanted herpes zoster subunit vaccine for older adults in Hong Kong.
    You JHS; Ming WK; Lee CF; Tsang OT; Chan PK
    Vaccine; 2018 Jul; 36(31):4610-4620. PubMed ID: 29958739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine".
    Giannelos N; Nishimwe ML; Lecrenier N
    Pharmacoeconomics; 2022 Oct; 40(10):1011-1012. PubMed ID: 36163540
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of the Recommendations of the Advisory Committee on Immunization Practices for the Recombinant Adjuvanted Zoster Subunit Vaccine.
    Le P; Rothberg MB
    JAMA Intern Med; 2018 Sep; 178(9):1277-1278. PubMed ID: 29987323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Authors' Reply to Comment on "Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine".
    Bilcke J; Beutels P
    Pharmacoeconomics; 2022 Oct; 40(10):1013-1014. PubMed ID: 36163539
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines.
    de Boer PT; van Lier A; de Melker H; van Wijck AJM; Wilschut JC; van Hoek AJ; Postma MJ
    BMC Med; 2018 Dec; 16(1):228. PubMed ID: 30518427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In adults ≥ 70 years of age, an adjuvanted herpes zoster subunit vaccine reduced herpes zoster at a mean 3.7 years.
    Sacks HS
    Ann Intern Med; 2017 Jan; 166(2):JC5. PubMed ID: 28114461
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolution of Herpes Zoster Vaccines and Their Economic Value.
    Najafzadeh M
    JAMA Intern Med; 2018 Feb; 178(2):258-259. PubMed ID: 29297047
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Usage of the Adjuvanted Herpes Zoster Subunit Vaccine (HZ/su): Revaccination of Recipients of Live Attenuated Zoster Vaccine and Coadministration With a Seasonal Influenza Vaccine.
    Oxman MN; Harbecke R; Koelle DM
    J Infect Dis; 2017 Dec; 216(11):1329-1333. PubMed ID: 29029303
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vaccines against Herpes zoster: Effectiveness, safety, and cost/benefit ratio].
    Ferahta N; Achek I; Dubourg J; Lang PO
    Presse Med; 2016 Feb; 45(2):162-76. PubMed ID: 26724874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.
    Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L
    J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited Focus in Evaluation of Vaccine Cost-effectiveness.
    Curran D; Van Oorschot D; Buck P
    JAMA Intern Med; 2018 Nov; 178(11):1563-1564. PubMed ID: 30398554
    [No Abstract]   [Full Text] [Related]  

  • 13. Limited Focus in Evaluation of Vaccine Cost-effectiveness-Reply.
    Le P; Rothberg MB
    JAMA Intern Med; 2018 Nov; 178(11):1564. PubMed ID: 30398559
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults.
    Le P; Rothberg MB
    JAMA Intern Med; 2018 Feb; 178(2):248-258. PubMed ID: 29297049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary regarding: Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. H Lal, AL Cunningham, O Godeaux et al., N Engl J Med 372:2087-2096, 2015.
    Yancey KB
    Dermatol Ther; 2016 Sep; 29(5):300-301. PubMed ID: 26798973
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States.
    Curran D; Patterson B; Varghese L; Van Oorschot D; Buck P; Carrico J; Hicks K; Lee B; Yawn B
    Vaccine; 2018 Aug; 36(33):5037-5045. PubMed ID: 30017145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older.
    Schwarz TF; Aggarwal N; Moeckesch B; Schenkenberger I; Claeys C; Douha M; Godeaux O; Grupping K; Heineman TC; Fauqued ML; Oostvogels L; Van den Steen P; Lal H
    J Infect Dis; 2017 Dec; 216(11):1352-1361. PubMed ID: 29029224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial.
    Godeaux O; Kovac M; Shu D; Grupping K; Campora L; Douha M; Heineman TC; Lal H
    Hum Vaccin Immunother; 2017 May; 13(5):1051-1058. PubMed ID: 28068212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the potential public health impact of Herpes Zoster vaccination in Germany.
    Curran D; Van Oorschot D; Varghese L; Oostvogels L; Mrkvan T; Colindres R; von Krempelhuber A; Anastassopoulou A
    Hum Vaccin Immunother; 2017 Oct; 13(10):2213-2221. PubMed ID: 28708959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
    Lal H; Cunningham AL; Godeaux O; Chlibek R; Diez-Domingo J; Hwang SJ; Levin MJ; McElhaney JE; Poder A; Puig-Barberà J; Vesikari T; Watanabe D; Weckx L; Zahaf T; Heineman TC;
    N Engl J Med; 2015 May; 372(22):2087-96. PubMed ID: 25916341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.